Quick, Armand J.
October 1959
Angiology;Oct1959, Vol. 10 Issue 5, p386
Academic Journal
The fluidity of the blood is maintained and safeguarded by (1) the relative slowness of thrombin generation in blood, and (2) the prompt removal of thrombin from circulating blood. The slowness of thrombin production is due in part to the absence of preformed thromboplastin in the blood, the barriers that prevent the entrance of tissue thromboplastin, and the chemical stability of the primary clotting factors. The speed of the clotting reaction depends on thrombin, the agent, through which the autocatalytic reaction is mediated. In the absence of thrombin the clotting reaction cannot proceed. Thrombin is promptly and effectively removed from blood by virtue of its affinity for fibrin surface. When thrombin is generated in the blood or is injected intravenously, the fibrin fibrils that are produced adsorb it, thereby removing it promptly. Presumably both the fibrin filaments and the adsorbed thrombin are destroyed in the capillary bed. By virtue of this mechanism, no accumulation of thrombin is permitted and the potential chain reaction is effectively checked.


Related Articles

  • Bleeding Mechanisms With Special Attention to Coagulation Disorders. Halldorsson, S.; Connelly, John P. // Clinical Pediatrics;Jan1968, Vol. 7 Issue 1, p34 

    The article discusses bleeding mechanisms focusing on coagulation disorders. The case of an adult male experiencing pain and swelling is reviewed revealing a diagnosis of thromboplastin inhibitory factor. The case offers a perspective on the three main mechanisms involved in the control of...

  • Factor XIII deficiency (Fibrin stabilizing factor). Jim, Robert T. S. // Hawaii Medical Journal;Oct2008, Vol. 67 Issue 10, p270 

    Factor XIII defi ciency (Fibrin stabilizing Factor or FSF) is a rare coagulation defect. The only patient believed to have this disorder in Hawai'i is presented in this report.

  • Elevated Plasma Levels of Fibrin Degradation Products by Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation. Matsumoto, Takeshi; Wada, Hideo; Nobori, Tsutomu; Nakatani, Kaname; Onishi, Katsuya; Nishikawa, Masakatsu; Shiku, Hiroshi; Kazahaya, Yumiko; Sawai, Tokio; Koike, Kaoru; Matsuda, Michio // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p391 

    Plasma levels of granulocyte-derived elastase (GE-XDP), D-dimer, and soluble fibrin (SF) were examined in 177 patients with disseminated intravascular coagulation (DIC) of various etiologies. Plasma levels of GE-XDP and D-dimer, but not SF, were significantly high in patients with sepsis and...

  • Factor XII, Kininogen and Plasma Prekallikrein in Abnormal Pregnancies. Sugi, T.; Makino, T. // Current Drug Targets;Aug2005, Vol. 6 Issue 5, p551 

    Factor XII, plasma prekallikrein and high molecular weight kininogen were first identified as coagulation proteins in the intrinsic pathway because patients deficient in these proteins had marked prolongation of in vitro surfaceactivated coagulation time. However, deficiencies of these proteins...

  • Congenital Blood Coagulation Factor XIII Deficiency and Perinatal Management. Ichinose, Akitada; Asahina, Toshihiko; Kobayashi, Takao // Current Drug Targets;Aug2005, Vol. 6 Issue 5, p541 

    Transglutaminases are at least 9 enzymes which cross-link a number of proteins. This type of reaction not only enhances the original functions of substrate proteins, but also adds new functions to them. Factor XIII (FXIII) is a plasma transglutaminase circulating in blood as a heterotetramer and...

  • Extravascular fibrin,plasminogen activator, plasminogen activator inhibitors,and airway hyperresponsiveness. Wagers, Scott S.; Norton, Ryan J.; Rinaldi, Lisa M.; Bates, Jason H.T.; Sobel, Burton E.; Irvin, Charles G. // Journal of Clinical Investigation;Jul2004, Vol. 114 Issue 1, p104 

    Mechanisms underlying airway hyperresponsiveness are not yet fully elucidated. One of the manifestations of airway inflammation is leakage of diverse plasma proteins into the airway lumen. They include fibrinogen and thrombin. Thrombin cleaves fibrinogen to form fibrin, a major component of...

  • Functional Determination of Factor XII in Plasma. Schousboe, Inger; Røjkær, Rasmus; Lintner, Rita // Clinical & Applied Thrombosis/Hemostasis;Spring1996, Vol. 2 Issue 2, p123 

    Clinical assays for factor XII determination are based on measurements of coagulation time in a multifactorial assay requiring the availability of factor XII-deficient plasma, and the determination is affected by the presence of heparin. Another way of determining the amount of functionally...

  • Simulating fibrin clotting time. Marx, Gerard // Medical & Biological Engineering & Computing;Mar2006, Vol. 44 Issue 1/2, p79 

    The clotting time (CT) of fibrinogen mixed with thrombin decreased, then increased with increasing fibrinogen levels. By contrast, log CT decreased monotonically with respect to the log level of activating enzyme (thrombin or reptilase). Here, the CT was determined over a large range of...

  • Quantitative assessment of procoagulant activity in isolated rat glomeruli. de Prost, Dominique; Kanfer, Alain; Le Floch, Véronique // Kidney International;Sep1985, Vol. 28 Issue 3, p566 

    Presents the quantitative assessment of procoagulant activity in isolated rat glomeruli. Existence of a tissue factor-like in tissue extracts from kidneys; Usefulness of the technique in investigating further mechanisms of deposition of fibrin; Details of the process.


Read the Article


Sign out of this library

Other Topics